131707-24-9Relevant articles and documents
Preparation method of arbidol intermediate
-
Paragraph 0028, (2020/07/02)
The invention discloses a preparation method of an arbidol intermediate. Ethyl acetoacetate, monomethylamine and p-benzoquinone used as initial raw materials undergo methylation, cyclization, acetylation, bromination and benzene vulcanization to prepare the target compound ethyl 5-hydroxy-6-bromo-2-phenylthiomethyl-1-methylindole-3-carboxylate. The preparation method of the arbidol intermediate issimple and convenient to operate, cheap and easily available in raw materials, high in yield, low in cost, good in quality, environment-friendly, mild in reaction condition, high in safety productioncoefficient and suitable for large-scale industrial production.
5,6-indole dioxane derivatives and preparation method and application thereof
-
, (2019/10/01)
The invention belongs to the field of drug synthesis, and particularly relates to a 5,6-indolo dioxane derivative and a preparation method and application thereof. The invention provides the 5,6-indolo dioxane derivative and the preparation method and application thereof. The derivative has certain inhibiting effect on HBV and low toxicity, and is expected to be further used for development of drugs for treating diseases caused by HBV infection, especially for preparing of drugs for treating and preventing viral hepatitis B.
Structure-based optimization and synthesis of antiviral drug Arbidol analogues with significantly improved affinity to influenza hemagglutinin
Wright, Zo? V.F.,Wu, Nicholas C.,Kadam, Rameshwar U.,Wilson, Ian A.,Wolan, Dennis W.
supporting information, p. 3744 - 3748 (2017/07/27)
Influenza is a highly contagious respiratory viral infection responsible for up to 50,000 deaths per annum in the US alone. The need for new therapeutics with novel modes of action is of paramount importance. We determined the X-ray structure of Arbidol with influenza hemagglutinin and found it was located in a distinct binding pocket. Herein, we report a structure-activity relationship study based on the co-complex combined with bio-layer interferometry to assess the binding of our compounds. Addition of a meta-hydroxy group to the thiophenol moiety of Arbidol to replace a structured water molecule in the binding pocket resulted in a dramatic increase in affinity against both H3 (1150-fold) and H1 (98-fold) hemagglutinin subtypes. Our analogues represent novel leads to yield more potent compounds against hemagglutinin that block viral entry.